[Form 3] Sight Sciences, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Sight Sciences (SGHT) reported an officer’s initial beneficial ownership on Form 3 effective 11/05/2025. The Chief Financial Officer beneficially owns 146,026 shares, including 28,252 shares of common stock and 117,774 restricted stock units subject to vesting conditions. Derivative holdings include stock options for 27,500 shares at $10.96 expiring 05/24/2031, 13,100 shares at $17.52 expiring 02/08/2032, and 14,400 shares at $9.78 expiring 03/16/2033, each with time-based monthly vesting as described.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rodberg James

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/05/2025

3. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	146,026(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	05/24/2031	Common Stock	27,500	$10.96	D
Stock Option (Right to Buy)	(3)	02/08/2032	Common Stock	13,100	$17.52	D
Stock Option (Right to Buy)	(4)	03/16/2033	Common Stock	14,400	$9.78	D

Explanation of Responses:

1. Includes (i) 28,252 shares of Common Stock, and (ii) 117,774 restricted stock units which are subject to vesting conditions.

2. These options were granted on May 25, 2021 and became exercisable as to 25% of the underlying securities May 16, 2022, with the remainder vesting in 36 substantially equal installments on a monthly basis thereafter, subject to the Reporting Person's continued service to the Company through each such date.

3. These options were granted on February 9, 2022 and vest in 48 substantially equal installments on a monthly basis commencing February 1, 2022, subject to the Reporting Person's continued service to the Company through each such date.

4. These options were granted on March 16, 2023 and vest in 48 substantially equal installments on a monthly basis commencing February 1, 2023, subject to the Reporting Person's continued service to the Company through each such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/Jeremy Hayden, Attorney-in-Fact for James Rodberg	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.